Authors: Di Leo, A Larsimont, D Gancberg, D Jarvinen, T Beauduin, M Vindevoghel, A Michel, J Focan, C Ries, F Gobert, P Closon-Dejardin, MT Dolci, S Rouas, G Paesmans, M Lobelle, JP Isola, J Piccart, MJ

Citation: A. Di Leo et al., HER-2 and topo-isomerase II alpha as predictive markers in a population ofnode-positive breast cancer patients randomly treated with adjuvant CMF orepirubicin plus cyclophosphamide, ANN ONCOL, 12(8), 2001, pp. 1081-1089

Authors: Piccart, MJ Di Leo, A Beauduin, M Vindevoghel, A Michel, J Focan, C Tagnon, A Ries, F Gobert, P Finet, C Closon-Dejardin, MT Dufrane, JP Kerger, J Liebens, F Beauvois, S Bartholomeus, S Dolci, S Lobelle, JP Paesmans, M Nogaret, JM

Citation: Mj. Piccart et al., Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer, J CL ONCOL, 19(12), 2001, pp. 3103-3110

Authors: Focan, C Beauduin, M Salamon, E de Greve, J de Wasch, G Lobelle, JP Majois, F Tagnon, A Tytgat, J van Belle, S Vandervellen, R Vindevoghel, A

Citation: C. Focan et al., Adjuvant high-dose medroxyprogesterone acetate for early breast cancer: 13years update in a multicentre randomized trial, BR J CANC, 85(1), 2001, pp. 1-8

Authors: Focan, C Bury, J Beauduin, M Herman, ML Vindevoghel, A Brohee, D Lecomte, M

Citation: C. Focan et al., Adjuvant intraportal chemotherapy for Dukes B2 and C colorectal cancer also receiving systemic treatment: results of a multicenter randomized trial, ANTI-CANC D, 11(7), 2000, pp. 549-554

Authors: Focan, C Bury, J Beauduin, M Herman, ML Vindevoghel, A Lecomte, M Brohee, D Canon, JL Focan-Henrard, D

Citation: C. Focan et al., Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer, ANTICANC R, 20(6C), 2000, pp. 4665-4672

Authors: Vanhooteghem, O Richert, B Vindevoghel, A Vandenbossche, L Vandeveire, A de la Brassinne, M

Citation: O. Vanhooteghem et al., Subungual abscess: a new ungual side-effect related to docetaxel therapy, BR J DERM, 143(2), 2000, pp. 462-464